Results 151 to 160 of about 4,011,812 (307)

The Editor's Choice for Issue 4, Volume 6. [PDF]

open access: yesInt J Neonatal Screen, 2021
Schielen PCJI.
europepmc   +1 more source

Exon 7 splicing of ERα predicts poor prognosis and increases phenotypic heterogeneity in luminal a subtype breast cancer

open access: yesFEBS Open Bio, EarlyView.
ERα splice variant ERα∆7 lacks the C‐terminus, and its expression may change phenotypes of breast cancers. Our results showed that ERα∆7 is found in the luminal A subtype, and elevated ERα∆7 levels are linked to improved cell survival with lower proliferation and migration.
Long Wai Tsui   +10 more
wiley   +1 more source

Volume (6) Issue (2) - Whole volume 1-458 [PDF]

open access: yesTranscultural Journal of Humanities and Social Sciences
doaj   +1 more source

Editorial volume 6 número 1

open access: yesNavus: Revista de Gestão e Tecnologia, 2016
Nadi Helena Presser, Eli Lopes da Silva
doaj   +1 more source

BioTM Buzz (Volume 6, Issue 2). [PDF]

open access: yesBioeng Transl Med, 2021
Anselmo AC.
europepmc   +1 more source

Development of human monoclonal antibodies against TARM1 by yeast display

open access: yesFEBS Open Bio, EarlyView.
Human monoclonal antibodies against TARM1 are generated by yeast display‐guided selection. These antibodies bind to soluble and cell‐surface forms of TARM1. Also, these antibodies exhibit agonistic activity in the NFAT‐GFP reporter assay, indicating that TARM1 signaling can be functionally modulated by antibodies and suggesting TARM1 as a potential ...
Rikio Yabe   +5 more
wiley   +1 more source

Volume 6 Credits [PDF]

open access: yes
Credits, Volume 6
core  

BioTM Buzz (Volume 6, Issue 1). [PDF]

open access: yesBioeng Transl Med, 2021
Anselmo AC.
europepmc   +1 more source

Establishing an assay to evaluate d‐amino acid oxidase enzyme kinetics and inhibition using WST‐8 redox dye

open access: yesFEBS Open Bio, EarlyView.
This study investigated a novel WST‐8‐based assay for evaluating d‐Amino acid oxidase (DAO) inhibitors. We confirmed its effectiveness using known inhibitors and found that uremic toxins possess relatively weak inhibitory activity compared to existing drugs.
Kahoko Miyake   +4 more
wiley   +1 more source

Home - About - Disclaimer - Privacy